GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Nhu Co Ltd (SZSE:002001) » Definitions » Beneish M-Score

Zhejiang Nhu Co (SZSE:002001) Beneish M-Score : -2.61 (As of May. 24, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Nhu Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.61 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Zhejiang Nhu Co's Beneish M-Score or its related term are showing as below:

SZSE:002001' s Beneish M-Score Range Over the Past 10 Years
Min: -3.26   Med: -2.42   Max: -0.74
Current: -2.61

During the past 13 years, the highest Beneish M-Score of Zhejiang Nhu Co was -0.74. The lowest was -3.26. And the median was -2.42.


Zhejiang Nhu Co Beneish M-Score Historical Data

The historical data trend for Zhejiang Nhu Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Nhu Co Beneish M-Score Chart

Zhejiang Nhu Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.22 -2.23 -2.16 -2.52 -2.74

Zhejiang Nhu Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.67 -2.64 -2.69 -2.74 -2.61

Competitive Comparison of Zhejiang Nhu Co's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Nhu Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Zhejiang Nhu Co's Beneish M-Score falls into.



Zhejiang Nhu Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Zhejiang Nhu Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0237+0.528 * 1.0161+0.404 * 1.1462+0.892 * 1.0502+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1315+4.679 * -0.057514-0.327 * 0.9014
=-2.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ¥3,735 Mil.
Revenue was 4498.764 + 4104.355 + 3593.668 + 3806.287 = ¥16,003 Mil.
Gross Profit was 1576.187 + 1290.525 + 1265.541 + 1284.154 = ¥5,416 Mil.
Total Current Assets was ¥13,057 Mil.
Total Assets was ¥39,619 Mil.
Property, Plant and Equipment(Net PPE) was ¥23,290 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥338 Mil.
Total Current Liabilities was ¥4,898 Mil.
Long-Term Debt & Capital Lease Obligation was ¥7,630 Mil.
Net Income was 869.623 + 603.03 + 617.98 + 840.071 = ¥2,931 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 480.895 + 2494.015 + 1389.793 + 844.635 = ¥5,209 Mil.
Total Receivables was ¥3,474 Mil.
Revenue was 3612.228 + 4023.966 + 3694.979 + 3907.048 = ¥15,238 Mil.
Gross Profit was 1144.827 + 1372.871 + 1242.896 + 1480.019 = ¥5,241 Mil.
Total Current Assets was ¥14,433 Mil.
Total Assets was ¥39,518 Mil.
Property, Plant and Equipment(Net PPE) was ¥22,238 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥285 Mil.
Total Current Liabilities was ¥8,432 Mil.
Long-Term Debt & Capital Lease Obligation was ¥5,432 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3735.02 / 16003.074) / (3474.041 / 15238.221)
=0.233394 / 0.227982
=1.0237

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5240.613 / 15238.221) / (5416.407 / 16003.074)
=0.343912 / 0.33846
=1.0161

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (13057.001 + 23289.854) / 39618.54) / (1 - (14432.64 + 22237.881) / 39517.62)
=0.08258 / 0.072046
=1.1462

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=16003.074 / 15238.221
=1.0502

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 22237.881)) / (0 / (0 + 23289.854))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(338.079 / 16003.074) / (284.503 / 15238.221)
=0.021126 / 0.01867
=1.1315

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((7630.22 + 4898.26) / 39618.54) / ((5431.833 + 8431.506) / 39517.62)
=0.316228 / 0.350814
=0.9014

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2930.704 - 0 - 5209.338) / 39618.54
=-0.057514

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Zhejiang Nhu Co has a M-score of -2.61 suggests that the company is unlikely to be a manipulator.


Zhejiang Nhu Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Zhejiang Nhu Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Nhu Co (SZSE:002001) Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Jiangbei Road, Yulin Street, Xinchang County, Zhejiang Province, Shaoxing, CHN, 312500
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer and Anti-bacterial with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3 and coenzyme Q10 and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
Executives
Hu Bai Fan Director
Shi Guan Qun Directors, Directors, and Executives
Hu Bai Shan Directors, executives
Cui Xin Rong Director
Chen Xue Cao Supervisors
Zhou Gui Yang Director
Qiu Jin Zhuo Supervisors
Wang Xue Wen Directors, executives
Wang Zheng Jiang Director
Ye Yue Heng Director
Dong Xiao Fang Supervisors
Liang Xiao Dong Supervisors
Zhang Xiao Bo Supervisors
Wang Xu Lin Supervisors
Ding Zhong Jun Director

Zhejiang Nhu Co (SZSE:002001) Headlines

No Headlines